Novel potent 2,5-pyrrolidinedione peptidomimetics as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2012-01-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2011.12.048PMID 22206607
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aminopeptidase N (EC 3.4.11.2) inhibitors (2006 – 2010): a patent review

  2011cited by this paper
• Aminopeptidase‐N/CD13 is a potential proapoptotic target in human myeloid tumor cells

  2011cited by this paper
• Engineered Thermoplasma acidophilum factor F3 mimics human aminopeptidase N (APN) as a target for anticancer drug development.

  2011cited by this paper
• Aminopeptidase N (CD13) as a target for cancer chemotherapy

  2011cited by this paper
• Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells.

  2010cited by this paper
• Novel aminopeptidase N (APN/CD13) inhibitor 24F can suppress invasion of hepatocellular carcinoma cells as well as angiogenesis.

  2010cited by this paper
• Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Structure-based design, chemistry and activity evaluation. II.

  2010cited by this paper
• Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions

  2009cited by this paper
• Structure of aminopeptidase N from Escherichia coli complexed with the transition‐state analogue aminophosphinic inhibitor PL250

  2009cited by this paper
• Aminopeptidase N (APN/CD13) as a target for anti-cancer agent design.

  2008cited by this paper
• Structural basis for the unusual specificity of Escherichia coli aminopeptidase N.

  2008cited by this paper
• The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases.

  2008cited by this paper
• Aminopeptidase N (APN/CD13) is selectively expressed in vascular endothelial cells and plays multiple roles in angiogenesis.

  2006cited by this paper
• Design, synthesis, and evaluation of novel galloyl pyrrolidine derivatives as potential anti-tumor agents.

  2006cited by this paper
• Structure of aminopeptidase N from Escherichia coli suggests a compartmentalized, gated active site

  2006cited by this paper
• Caffeoyl pyrrolidine derivative LY52 inhibits tumor invasion and metastasis via suppression of matrix metalloproteinase activity.

  2006cited by this paper
• Aminopeptidase‐N/CD13 (EC 3.4.11.2) inhibitors: Chemistry, biological evaluations, and therapeutic prospects

  2005cited by this paper
• Progress in the development of aminopeptidase N (APN/CD13) inhibitors.

  2005cited by this paper
• Role of aminopeptidase in angiogenesis.

  2004cited by this paper
• Characterization of Glu350 as a critical residue involved in the N-terminal amine binding site of aminopeptidase N (EC 3.4.11.2): insights into its mechanism of action.

  1998cited by this paper
• LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions.

  1995cited by this paper
• Role of aminopeptidase N (CD13) in tumor‐cell invasion and extracellular matrix degradation

  1993cited by this paper

• The mercapturic acid pathway

  2019cites this paper
• Design of Aminopeptidase N Inhibitors as Anti-cancer Agents.

  2018cites this paper
• Discovery of novel non-competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)

  2017cites this paper
• An expedient synthesis of non-racemic N-alkylated pyrrolidin-2,5-diones and piperidin-2,6-diones as peptidomimetics

  2016cites this paper
• SYNTHESIS OF NEW HYDANTOINS BEARING GLUTARIMIDE OR SUCCINIMIDE MOIETY AND THEIR EVALUATION FOR CELL DIFFERENTIATION-INDUCING AND ANTI-ANGIOGENIC ACTIVITIES

  2015cites this paper
• Establishment of a screening protocol for identification of aminopeptidase N inhibitors

  2014cites this paper
• Inhibition of proteases as a novel therapeutic strategy in the treatment of metabolic, inflammatory and functional diseases of the gastrointestinal tract.

  2013cites this paper